We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$193M
AUM Growth
-$17.7M
Cap. Flow
+$7.46M
Cap. Flow %
3.87%
Top 10 Hldgs %
52.19%
Holding
80
New
22
Increased
10
Reduced
12
Closed
26
Avg Time Held Equity + Options
1.9 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
2.1 quarters
Top 10 Avg Time Held Equity only
1.6 quarters
Top 20 Avg Time Held Equity only
2.1 quarters

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$23.6M
2
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$9.19M
3
BIIB icon
Biogen
BIIB
+$4.6M
4
EGRX icon
Eagle Pharmaceuticals, Inc.
EGRX
+$3.86M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.69M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$6.61M
2
TMO icon
Thermo Fisher Scientific
TMO
+$6.28M
3
HCA icon
HCA Healthcare
HCA
+$5.27M
4
PBYI icon
Puma Biotechnology
PBYI
+$4.91M
5
PHG icon
Philips
PHG
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 59.72%
2 Miscellaneous 35.2%
3 Financials 4.17%
4 Technology 0.91%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SIOX
1
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$25M 12.99%
454,838
+451,125
+12,150% +$76.1M
2017 Q2
1 quarter
SAGE icon
2
PUT
DELISTED
Sage Therapeutics
SAGE
$11.9M 6.15%
190,400
+130,400
+217% +$10.2M
2017 Q1
2 quarters
QTNT
3
DELISTED
Quotient Limited Ordinary Shares
QTNT
$11.6M 6%
58,608
-520
-0.9% -$104K
2014 Q4
11 quarters
DMK
4
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$10.1M 5.25%
27,657
+25,907
+1,480% +$9.19M
2014 Q4
11 quarters
INSM icon
5
PUT
Insmed
INSM
$21.1B
$8.33M 4.32%
266,800
+200
+0.1% +$3.81K
2017 Q1
2 quarters
AET
6
DELISTED
Aetna Inc
AET
$8.03M 4.17%
50,523
-1,477
-3% -$231K
2016 Q4
3 quarters
SIOX
7
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$7.7M 3.99%
+139,862
New +$23.6M
2017 Q3
0 quarters
GSK icon
8
GSK
GSK
$92.6B
$6.97M 3.62%
137,355
+46,865
+52% +$2.38M
2016 Q4
3 quarters
AGIO icon
9
PUT
Agios Pharmaceuticals
AGIO
$1.8B
$5.55M 2.88%
83,100
– –
2017 Q2
1 quarter
SGEN
10
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$5.44M 2.82%
100,000
– –
2017 Q2
1 quarter
BIIB icon
11
Biogen
BIIB
$33.5B
$4.87M 2.53%
+15,549
New +$4.6M
2017 Q3
0 quarters
GMED icon
12
Globus Medical
GMED
$10.2B
$4.38M 2.27%
147,364
+33,964
+30% +$1.04M
2017 Q1
2 quarters
MDT icon
13
Medtronic
MDT
$118B
$4.34M 2.25%
55,844
+25,844
+86% +$2.15M
2017 Q1
2 quarters
KURA icon
14
Kura Oncology
KURA
$870M
$4.12M 2.14%
+275,731
New +$2.59M
2017 Q3
0 quarters
GSK icon
15
CALL
GSK
GSK
$92.6B
$4.06M 2.11%
+80,000
New +$4.06M
2017 Q3
0 quarters
RIGL icon
16
Rigel Pharmaceuticals
RIGL
$888M
$3.97M 2.06%
156,331
+21,759
+16% +$529K
2016 Q1
6 quarters
AVNS icon
17
DELISTED
Avanos Medical
AVNS
$3.91M 2.03%
86,914
-13,685
-14% -$584K
2017 Q2
1 quarter
EGRX icon
18
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.81M 1.98%
+63,835
New +$3.86M
2017 Q3
0 quarters
EBS icon
19
Emergent Biosolutions
EBS
$353M
$3.65M 1.89%
+90,268
New +$3.27M
2017 Q3
0 quarters
ZBH icon
20
Zimmer Biomet
ZBH
$17.7B
$3.63M 1.89%
+31,964
New +$3.69M
2017 Q3
0 quarters
AAAP icon
21
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$3.56M 1.85%
52,582
-55,941
-52% -$2.72M
2015 Q4
7 quarters
PBYI icon
22
Puma Biotechnology
PBYI
$530M
$3.26M 1.69%
27,221
-52,800
-66% -$4.91M
2017 Q1
2 quarters
ZTS icon
23
PUT
Zoetis
ZTS
$31.1B
$3.19M 1.65%
+50,000
New +$3.13M
2017 Q3
0 quarters
PHG icon
24
Philips
PHG
$24.3B
$2.79M 1.45%
89,359
-168,310
-65% -$4.9M
2016 Q1
6 quarters
ICLR icon
25
Icon
ICLR
$12.7B
$2.69M 1.39%
+23,604
New +$2.51M
2017 Q3
0 quarters
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Sio Capital Management held 80 positions worth $193M, down 8.4% from $210M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sio Capital Management deployed $7.46M of net new capital in Q3 2017, opening 22 new positions and adding to 10 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 139,862 shares worth $7.7M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Sanofi, an estimated $6.61M trimmed.

  • Sio Capital Management's largest Q3 2017 buy was Sio Gene Therapies Inc. Common Stock: 139,862 shares worth $7.7M.
  • Sio Capital Management added most to DMK Pharmaceuticals Corporation Common Stock in Q3 2017, an estimated $9.19M increase.
  • Sio Capital Management's biggest Q3 2017 reduction was Sanofi, cutting an estimated $6.61M.
  • Sio Capital Management fully exited Thermo Fisher Scientific in Q3 2017, selling an estimated $6.28M.
  • Sio Capital Management's ten largest holdings make up 52% of its $193M portfolio in Q3 2017.
  • Sio Capital Management opened 22 new positions and closed 26 in Q3 2017.
  • Sio Capital Management's portfolio value fell 8.4% quarter-over-quarter to $193M.

Based on Sio Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.